Connection

Michelle Willicombe to Pyrimidines

Back to Details
This is a "connection" page, showing publications Michelle Willicombe has written about Pyrimidines.
Michelle Willicombe
Connection Strength
0.031
Pyrimidines
  1. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 12; 22(1):270.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.